[Anxiety and depression in type II diabetics]

Area of Science:

• Medical Research
• Psychiatry
• Endocrinology

Background:

• Diabetes Mellitus Type II (DM) is a chronic condition requiring ongoing management.
• Mental health comorbidities, such as depression and anxiety, can impact patient outcomes.
• Understanding the prevalence of psychiatric pathology in DM patients is crucial for comprehensive care.

Purpose of the Study:

• To determine the prevalence of depression and anxiety levels in patients with DM type II.
• To compare psychiatric pathology in DM patients versus a non-diabetic control group.
• To analyze the relationship between psychiatric conditions and various diabetes-related variables.

Main Methods:

• A comparative crossover study design was employed.
• Participants included DM type II patients and a matched non-diabetic control group.
• Anxiety was measured using the Stai test, and depression using the Beck test.

Main Results:

• The prevalence of depression was 27% in the DM group, compared to 47% in the control group (p = 0.001).
• Anxiety levels were also significantly lower in the diabetic cohort.
• No statistically significant relationships were observed between depression/anxiety and DM duration, treatment, complications, self-monitoring, or glycemic control.

Conclusions:

• Diabetic patients in this study exhibited a substantially lower prevalence of psychiatric pathology than the control group.
• No association was found between depression and anxiety levels and key diabetes-related variables.
• These findings suggest a potentially protective effect of DM or its management on psychiatric health, warranting further investigation.